First Hawaiian Bank Acquires New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

First Hawaiian Bank acquired a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 8,793 shares of the company’s stock, valued at approximately $749,000. Other large investors also recently modified their holdings […]

Related Keywords

Hawaii ,United States ,Hawaiian ,Neurocrine Biosciences ,Kevin Charles Gorman ,Piper Sandler ,Stephena Sherwin ,Kevinc Gorman ,Morgan Stanley ,Neurocrine Biosciences Inc ,Zacks Investment Research ,Red Spruce Capital ,Nasdaq ,Stonnington Group ,First Hawaiian Bank ,Zeke Capital Advisors ,Get Rating ,Spruce Capital ,Bay Capital Management ,Capital Advisors ,Director Stephen ,Charles Gorman ,Investment Research ,Biosciences Profile ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,